We aim to advance the potential of combined pathway modulation in oncology. Through intensive research in both cancer immunity and tumor targets, we aspire to make fundamental scientific discoveries that will provide a comprehensive, personalized approach in the fight against cancer.
Discover more about ongoing research in tumor targets and pathways.
Learn more about the science of harnessing a potential immune response in patients with cancer.
The compounds and their uses mentioned on this website are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. Do you wish to proceed?
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.